Resona Asset Management Co. Ltd. Buys Shares of 193,742 Intuitive Surgical, Inc. (NASDAQ:ISRG)

Resona Asset Management Co. Ltd. purchased a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the fourth quarter, HoldingsChannel reports. The fund purchased 193,742 shares of the medical equipment provider’s stock, valued at approximately $101,613,000. Intuitive Surgical makes up approximately 0.6% of Resona Asset Management Co. Ltd.’s holdings, making the stock its 26th biggest position.

Several other institutional investors and hedge funds have also modified their holdings of the company. Norges Bank acquired a new stake in shares of Intuitive Surgical in the fourth quarter worth approximately $2,401,493,000. Proficio Capital Partners LLC boosted its holdings in shares of Intuitive Surgical by 89,098.8% in the 4th quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider’s stock valued at $495,845,000 after purchasing an additional 948,902 shares during the last quarter. Raymond James Financial Inc. purchased a new stake in shares of Intuitive Surgical during the 4th quarter valued at $313,769,000. Wilmington Savings Fund Society FSB increased its holdings in shares of Intuitive Surgical by 15,322.2% during the 3rd quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock worth $272,980,000 after buying an additional 552,058 shares during the last quarter. Finally, Vanguard Group Inc. raised its position in shares of Intuitive Surgical by 1.1% in the 4th quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider’s stock worth $16,813,478,000 after buying an additional 360,591 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

NASDAQ ISRG opened at $451.58 on Friday. The company has a market capitalization of $160.84 billion, a price-to-earnings ratio of 70.45, a price-to-earnings-growth ratio of 5.85 and a beta of 1.55. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The company’s fifty day moving average price is $545.18 and its two-hundred day moving average price is $532.30.

Insider Transactions at Intuitive Surgical

In related news, CFO Jamie Samath sold 94 shares of the company’s stock in a transaction that occurred on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the sale, the chief financial officer now directly owns 2,630 shares of the company’s stock, valued at approximately $1,502,019.30. This represents a 3.45 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of the business’s stock in a transaction on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the sale, the director now owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 33,754 shares of company stock valued at $17,691,621. Insiders own 0.70% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on the company. Barclays boosted their price target on Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. Royal Bank of Canada increased their target price on shares of Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. Robert W. Baird reduced their price target on shares of Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating on the stock in a research report on Tuesday, March 18th. JPMorgan Chase & Co. increased their price objective on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Finally, Piper Sandler restated an “overweight” rating and set a $670.00 target price (up previously from $538.00) on shares of Intuitive Surgical in a report on Friday, January 24th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have assigned a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $611.86.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.